The Comparative Effects of Transdermal and Intramuscular Diclofenac for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy


Affiliations

  • Dr. Vasantrao Pawar Medical College Hospital & RC, Department of Anaesthesia, Nashik, 422003
  • Dr. Vasantrao Pawar Medical College Hospital & RC, Department of Anaesthesia, Nashik, 422003, India

Abstract

Aims and Objectives: To compare the analgesic effectiveness of transdermal diclofenac patch and intramuscular diclofenac in patients undergoing laparoscopic cholecystectomy. To compare the adverse effects of transdermal Diclofenac patch and intramuscular diclofenac. Methods: Sixty ASA I and II patients of either sex aged eighteen to sixty years ready for laparoscopic cholecystectomy were enclosed during this study. Patients were divided into 2 groups, A (n = 30) received transdermal diclofenac patch (100 mg) three hours before surgery B (n = 30) intramuscular diclofenac (75 mg) was given forty five minutes before surgery. Postoperative pain was assessed using Visual Analogue Scale (VAS). Adverse effects were noted over a period of twelve hours. Patients with VAS score greater than 3 received intravenous tramadol 2mg/ kg to relieve pain. Results: In each group the VAS scores were higher for ten hours post surgery. There was no significant difference in the surgical pain in both the groups. There was no significant difference in both the groups statistically for the need of rescue analgesia. Erythema was observed in group A patients whereas pain at injection site and rubor was observed in group B who received the injection diclofenac.Conclusion: Diclofenac skin patch and IM injection are unit comparable in terms of effectiveness for pain relief in surgical laparoscopic cholecystectomy patients. Transdermal patch is thought of as an efficient, non-invasive and value effective means of managing surgical pain.

Keywords

Diclofenac, Shot, Skin Patch, VAS scores

Subject Discipline

Anaesthesia

Full Text:

References

Hepner, David L. Preventive analgesia: What will it very mean? Medicine. 2000; 93(5):1368.

Ong CKS, Lirk P, Saymour R. The effectiveness of preventive physiological state for acute surgical pain management- A metanalysis. Anaesthesia and Physiological State. 2005; 100:575–73.

Pointers for the utilization of Nonsteroidal. Medicament medicine within the perioperative amount. The Royal School of Anaesthetists; 1998 Mar.

Shang AB, Gan TJ. Optimising surgical pain management within the ambulant Patient. Medicine. 2003; 63(9):855–67.

Sachs CJ. Oral analgesics for acute nonspecific pain. Am Fam Doctor. 2005; 71:913–8.

Bannwarth B. Do selective cyclo-oxygenase-2 inhibitors have a future? Drug Safety. 2005; 28(3):183–9 https://doi.org/10.2165/00002018-200528030-00001 PMid:15733024

Naedal J, Brown K. NSAID-associated adverse effects and acid management aids to forestall them. A review of current treatment choices. Drug Safety. 2006; 29(2):119–32. https://doi.org/10.2165/00002018-200629020-00002

Vaile JH, Davis P. Topical NSAIDs for contractor Conditions. A review of the literature. Medicine. 1998; 56(5):783–99.

Bhargava GS, Sidhu AS, Bansal D, Bhatia AS. Comparative study within the management of surgical pain with diclofenac patch versus diclofenac injection. CIB Tech J Surg. 2015; 4(1):10–5.

Hadgraft J, Lane ME. Passive transdermic drug delivery systems. Recent issues and advances. Am J Drug Deliv. 2006; 4(3):153–60. https://doi.org/10.2165/00137696-200604030-00003


Refbacks

  • There are currently no refbacks.